г. Киев, ул. Терещенковская, 13, оф.22
Режим работы: пн.–пт. 1000–1900, сб. 1000–1700

Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor (склерозирующий панэнцефалит)

Scand J Immunol. 1973;2(4):367-74.

Related Articles, Links

Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor.

Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degre M.

PMID: 4797728 [PubMed - indexed for MEDLINE]

J Neurol. 1975 Dec 2;211(1):39-49.

Related Articles, Links

Transfer factor therapy in patients with subacute sclerosing panencephalitis.

Kackell YM, Grob PJ, Kreth WH, Kibler R, Meulen V.

Thirteen patients with subacute sclerosing panencephalitis (S.S.P.E.) at different stages of the disease were admitted for transfer factor treatment. The transfer factor was prepared from non-selected blood bank donors. The activity of the transfer factor was tested in patients with diseases other than S.S.P.E. and was found to be either clinically or immunologically active. Regardless of the number of transfer factor units applied a significant influence on the course of the disease was not apparant. The observed intermittant improvement of 3 patients was considered as spontaneous remission which is known to occur occasionally in S.S.P.E. The humoral and cellular immune response before and after transfer factor therapy did not reveal significant changes which could be correlated with transfer factor therapy.

PMID: 56430 [PubMed - indexed for MEDLINE]

Cell Immunol. 1975 Jun;17(2):560-6.

Related Articles, Links

Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes.

Mendes NF, Saraiva PJ, Santos OB.

PMID: 165007 [PubMed - indexed for MEDLINE]

Rev Alerg Mex. 1993 Sep-Oct;40(5):124-31.

Related Articles, Links

[Treatment of extrinsic bronchial asthma with transfer factor]

[Article in Spanish]

Valdes Sanchez AF, Martin Rodriguez OL, Lastra Alfonso G.

Servicio de alergologia, Hospital Clinico Quirurgico Hermanos Ameljeiras, La Habana, Cuba.

A group of 90 external asthmatics with cellular immunodeficiency or not was studied and treated during 10 months with transfer factor or double blind placebo. Total immunoglobulin serum studies (A, G, M and E), spontaneous rosette and intradermal tests, were made a month before the treatment's beginning and a month after the ending of the treatment. The patients were clinically evaluated every day in accordance to the intensity and the frequency of their crisis and with the immunological point of view of the tests made. There was not significant differences between the study groups treated with the transfer factor or not. Adverse reactions were not noticed.

Publication Types:

·         Clinical Trial

·         Randomized Controlled Trial

PMID: 9312340 [PubMed - indexed for MEDLINE] 

Вернуться в раздел